XOMA Royalty (XOMA) Operating Margin (2011 - 2026)
XOMA Royalty's (XOMA) quarterly Operating Margin came in at 3.9% in Q1 2026, down 15212.0% year-on-year from N/an in Q1 2025, and up 33.69% quarter-over-quarter from 5.88% in Q4 2025.
XOMA Royalty (XOMA) Operating Margin (2011 - 2026) Analysis & Trends
XOMA Royalty has disclosed Operating Margin across 16 years of filings, most recently posting 3.9% for Q1 2026.
- Operating Margin for Q1 2026 came in at 3.9%, down 15212.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.45% (up 28362.0% YoY), and the FY2025 annual result was 12.81%, up 15314.0% from the prior year.
- Operating Margin came in at 3.9% for Q1 2026 at XOMA Royalty, up from 5.88% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 148.22% in Q1 2025 to a low of 62560.0% in Q3 2024.
- The 5-year median for Operating Margin is 484.94% (2022), against an average of 4232.87%.
- Across the five-year window, Operating Margin sank 6186277 bps in 2024 and jumped 6196889 bps in 2025, its largest moves.
- XOMA Royalty's Operating Margin stood at 417.9% in 2022, then sank by 160 bps to 1087.51% in 2023, then sank by 33 bps to 1450.6% in 2024, then surged by 100 bps to 5.88% in 2025, then jumped by 34 bps to 3.9% in 2026.
- The last three Operating Margin figures came in at 3.9% (Q1 2026), 5.88% (Q4 2025), and 591.11% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -6.43% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | XOMA Royalty | 5.52 Mn | -60.56 Mn | - | -3.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.90% |
| Dec 31, 2025 | -5.88% |
| Sep 30, 2025 | -591.11% |
| Jun 30, 2025 | 91.60% |
| Mar 31, 2025 | 148.23% |
| Dec 31, 2024 | -1,450.60% |
| Sep 30, 2024 | -62,560.00% |
| Jun 30, 2024 | -200.58% |
| Mar 31, 2024 | -470.07% |
| Dec 31, 2023 | -1,087.51% |
| Sep 30, 2023 | -697.23% |
| Jun 30, 2023 | -865.84% |
| Mar 31, 2023 | -2,327.23% |
| Dec 31, 2022 | -417.90% |
| Sep 30, 2022 | -969.40% |
| Jun 30, 2022 | -484.94% |
| Mar 31, 2022 | -66.46% |
| Dec 31, 2021 | 15,182.50% |
| Sep 30, 2021 | -355.85% |
| Jun 30, 2021 | -340.07% |